 treatment travel diarrhea ciprofloxacin loperamid ciprofloxacin placebo-control random trial object safeti efficaci loperamid combin ciprofloxacin treatment travel diarrhea design double-blind placebo-control random clinic trial set unit armi hospit egypt particip unit militari personnel travel diarrhea militari exercis novemb person noncompli bloodi diarrhea antidiarrh medic entri studi intervent particip travel diarrhea ciprofloxacin mg day patient loperamid first dose mg loos stool mg/d placebo measur enterotoxigen escherichia coli patient shigella salmonella patient common main result hour symptom patient ciprofloxacin loperamid group ciprofloxacin placebo group odd ratio CI hour symptom group mean number stool loperamid much loperamid hour SE hour treatment conclus region enterotoxigen coli predomin caus travel diarrhea ciprofloxacin treatment ciprofloxacin benefit first hour treatment patient enterotoxigen coli regimen safe